{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T14:49:58Z","timestamp":1769179798341,"version":"3.49.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Ann Plast Surg"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Pemphigus is a group of autoimmune diseases of the skin and mucous membranes that is characterized by multiple bullae formation. It is caused by autoantibodies directed against the cell surface of keratinocytes, resulting in the loss of cell-cell adhesion of keratinocytes. This disease can be very debilitating and difficult to treat if large surface areas are involved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We performed a retrospective review of a complex case of pemphigus vulgaris in a 24-year-old man who develop partial-thickness skin lesions distributed throughout the entire body with a total body surface of 80% short after an episode of strep throat treated with amoxicillin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The patient had a complicated hospital course in which the standard treatment of the disease led to adverse effects that were successfully managed at our busy burn center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Pemphigus vulgaris is a complex skin disease in which treatment techniques carry their risk and must be tailored to the patient's specific needs. Treatment of this conditions at a burn center would be beneficial as demonstrated with conditions like Stevens-Johnson syndrome and toxic epidermal necrolysis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sap.0000000000003589","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T21:12:25Z","timestamp":1689369145000},"page":"62-63","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Pemphigus Vulgaris"],"prefix":"10.1097","volume":"91","author":[{"given":"Samuel","family":"Ruiz","sequence":"first","affiliation":[{"name":"Department of Surgery, Kendall Regional Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Puebla","sequence":"additional","affiliation":[{"name":"HCA Miami Burn Center, Miami, FL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Hernandez","sequence":"additional","affiliation":[{"name":"HCA Miami Burn Center, Miami, FL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Rubio","sequence":"additional","affiliation":[{"name":"HCA Miami Burn Center, Miami, FL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Young","sequence":"additional","affiliation":[{"name":"HCA Miami Burn Center, Miami, FL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haaris","family":"Mir","sequence":"additional","affiliation":[{"name":"HCA Miami Burn Center, Miami, FL."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib5-20250616","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s12325-016-0343-4","article-title":"Management of pemphigus vulgaris","volume":"33","year":"2016","journal-title":"Adv Ther"},{"key":"bib6-20250616","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2334\/josnusd.45.165","article-title":"Pemphigus vulgaris and complications of systemic corticosteroid therapy: a case report","volume":"45","year":"2003","journal-title":"J Oral Sci"},{"key":"bib7-20250616","first-page":"467","article-title":"Cutaneous mucormycosis: a fatal complication of immunosuppressant therapy for pemphigus vulgaris","volume":"15","year":"2017","journal-title":"Skinmed"},{"key":"bib8-20250616","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/08916934.2011.606452","article-title":"Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update","volume":"45","year":"2012","journal-title":"Autoimmunity"},{"key":"bib9-20250616","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A randomized double-blind trial of intravenous immunoglobulin for pemphigus","volume":"60","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"bib10-20250616","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jaad.2015.04.038","article-title":"The role of adjuvant therapy in pemphigus: a systematic review and meta-analysis","volume":"73","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"bib11-20250616","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1097\/BCR.0000000000000049","article-title":"The management of pemphigus vulgaris in a burn intensive care unit: a case report and treatment review","volume":"35","year":"2014","journal-title":"J Burn Care Res"},{"key":"bib13-20250616","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","year":"2006","journal-title":"N Engl J Med"},{"key":"bib14-20250616","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","volume":"57","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"bib15-20250616","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00004630-198305000-00005","article-title":"Clinical management: a burn center experience with toxic epidermal necrolysis","volume":"4","year":"1983","journal-title":"J Burn Care Rehabil"},{"key":"bib16-20250616","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archsurg.1984.01390170097019","article-title":"Improved treatment of the Stevens-Johnson syndrome","volume":"119","year":"1984","journal-title":"Arch Surg"},{"key":"bib17-20250616","first-page":"273","article-title":"Burn center care for patients with toxic epidermal necrolysis","volume":"180","year":"1995","journal-title":"J Am Coll Surg"},{"key":"bib18-20250616","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","article-title":"A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century","volume":"23","year":"2002","journal-title":"J Burn Care Rehabil"},{"key":"bib19-20250616","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/jbcr\/iraa038","article-title":"Updating the burn center referral criteria: results from the 2018 eDelphi consensus study","volume":"41","year":"2020","journal-title":"J Burn Care Res"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000003589","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T23:08:58Z","timestamp":1750115338000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000003589"}},"subtitle":["More Than Just a Skin Disease"],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000003589","relation":{},"ISSN":["1536-3708","0148-7043"],"issn-type":[{"value":"1536-3708","type":"electronic"},{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]}}}